Purdue Pharma bankruptcy judge to rule Friday on opioid settlement

1 minute read
Register now for FREE unlimited access to Reuters.com

Aug 25 (Reuters) - A U.S. judge in the Purdue Pharma bankruptcy case expects to rule on Friday on the OxyContin maker's request to approve its settlement of opioid-related litigation.

During a hearing on Wednesday, U.S. Bankruptcy Judge Robert Drain in White Plains, New York, said he plans to rule at the end of the week. A trial over the plan and settlement began on Aug. 12.

The deal, which Purdue says is worth more than $10 billion, has widespread support but is still opposed by nine U.S. states. Members of the Sackler family who own the company have said they will contribute about $4.5 billion in exchange for legal protections against opioid-related litigation.

Drain stated at the conclusion of Wednesday's hearing that Purdue, the Sacklers and the opposing states should continue efforts to reach a deal before Friday.

"I would encourage you ... to continue that work," he said.

Register now for FREE unlimited access to Reuters.com
Reporting by Maria Chutchian; editing by Grant McCool and Richard Pullin

Our Standards: The Thomson Reuters Trust Principles.

Thomson Reuters

Maria Chutchian reports on corporate bankruptcies and restructurings. She can be reached at maria.chutchian@thomsonreuters.com.